Enprostil Impairs Cholesterol and Fat Absorption

References

• Schwartz K, Zaro B, Burton P, Hunt J, Pennelly L, Sevelius H. Reduction of serum lipoproteins in man by the oral administration of a prostaglandin analogue (Enprostil). Atherosclerosis 1988; 71: 9–16
   PubMedGoogle Scholar
• Schwartz K, Zaro B, Reynolds J, Duffy J, Saito T, Hunt J, et al. Suppression of postprandial glucose, insulin, C-peptide, and gastric inhibitory polypeptide in man by a prostaglandin analogue (Enprostil). Horm Metab Res 1988; 20: 637–40
   PubMedGoogle Scholar
• Raeven G M, Swislocki A LM, Jeng C Y, Hollenbeck C K, Schwartz K, Chen Y DI. Effect of enprostil on plasma glucose, insulin, and lipid metabolism in patients with non-insulin-dependent diabetes mellitus. Horm Metab Res 1988; 20: 633–6
   PubMedGoogle Scholar
• Schwartz K, Saito T. Suppression of alimentary lipemia in man by a prostaglandin analogue (Enprostil). Atherosclerosis 1989; 79: 231–6
   PubMedGoogle Scholar
• Davis T ME, Proby C, Strong J A, Thompson G R, Massey H, Scott R, et al. Effect of enprostil on glucose and lipid metabolism in type A diabetes. Diab Med 1989; 6: 400–5
   PubMedGoogle Scholar
• Nauck M, Harter S, Ebert R, Creutzfeldt W. Effects of four orally administered analogues of prostaglandin E1 and E2 on glucose tolerance and on the secretion of pancreatic and gastrointestinal hormones in man. Eur J Clin Invest 1989; 19: 298–305
   PubMed Web of Science ®Google Scholar
• Wallace J L. Prostaglandins, NSAIDs, and cytoprotection. Gastroenterol Clin North Am 1992; 21: 631–41
   PubMed Web of Science ®Google Scholar
• Nicholl C G, Carolan G, Sevelius H, Bloom S R. Enprostil reduces the postprandial rises in insulin and glucose-dependent insulinotropic peptide and delays small intestinal transit time. Diabetologia 1986; 29: 575A
   Web of Science ®Google Scholar
• Friedewald W T, Levy R I, Fredrickson D S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972; 18: 499–502
   PubMed Web of Science ®Google Scholar
• Wilson D E, Chan I-F, Ball M. Plasma lipoprotein retinoids after vitamin A feeding in normal man. Minimal appearance of retinyl esters among low-density lipoproteins. Metab Clin Exp 1983; 32: 514–7
   PubMedGoogle Scholar
• Berr F, Kern F, Jr. Plasma clearance of chylomicrons labelled with retinyl palmitate in healthy human subjects. J Lipid Res 1984; 25: 805–12
   PubMed Web of Science ®Google Scholar
• Olson J A. Metabolism and function of vitamin A. Fed Proc 1969; 28: 1670–7
   PubMedGoogle Scholar
• Lipid Research Clinics Program Manual of Laboratory Operations. Lipid and lipoprotein analysis. DHEW Publications No (NIH) 75–628, National Heart and Lung Institute, Bethesda, MD 1974; 5–59
   Google Scholar
• Weintraub M S, Eisenberg S, Breslow J L. Different patterns of postprandial lipoprotein metabolism in normal, type IIa, IIb, type III and type IV hyperlipoproteinemic individuals. Effects of treatment with cholestyramine and gemfibrozil. J Clin Invest 1987; 79: 1110–9
   PubMed Web of Science ®Google Scholar
• Crouse J, Grundy S M. Evaluation of continuous isotope feeding method of measurement of cholesterol absorption in man. J Lipid Res 1978; 6: 967–71
   Google Scholar
• Ahlström A, Räsänen L, Kuvaja K. A method of data processing for food consumption surveys. Ann Acad Sci Fenn [Biol] 1972; 194: 1–8
   Google Scholar
• Miettinen T A. Gas-liquid chromatographic determination of fecal neutral sterols using a capillary column. Clin Chim Acta 1982; 124: 245–8
   PubMed Web of Science ®Google Scholar
• Grundy S M, Ahrens E H, Jr, Miettinen T A. Quantitative isolation and gas-liquid chromatographic analysis of total fecal bile acids. J Lipid Res 1965; 6: 397–410
   PubMed Web of Science ®Google Scholar
• Miettinen T A, Ahrens E H, Jr, Grundy S M. Quantitative isolation and gas-liquid chromatographic analysis of total dietary and fecal neutral steroids. J Lipid Res 1965; 6: 411–24
   PubMed Web of Science ®Google Scholar
• Van de Kamer J H, ten Bokkel Huinink H, Wevers H A. Rapid method for the determination of fat in feces. J Biol Chem 1949; 177: 347–55
   PubMed Web of Science ®Google Scholar
• Miettinen T A. Effects of neomycin alone and in combination with cholestyramine on serum cholesterol and fecal steroids in hypercholesterolemic subjects. J Clin Invest 1979; 64: 1485–93
   PubMed Web of Science ®Google Scholar
• Vanhanen H, Kesaniemi Y A, Miettinen T A. Pravastatin lowers serum cholesterol, cholesterol precursor sterols, fecal steroids and cholesterol absorption in man. Metabolism 1992; 41: 588–1
   PubMed Web of Science ®Google Scholar
• Miettinen T A, Helve E, Ojala J-P, Tikkanen M. Inhibition of dietary cholesterol absorption during lovastatin (mevinolin) treatment. Drug Invest 1990; 2(Suppl 2)9–35
   Google Scholar
• Miettinen T A, Vanhanen H, Ojala J-P, Tikkanen M. Cholesterol sterols and fecal elimination of cholesterol during statin and fibrate treatment. Atherosclerosis 1992; 97: S73–80
   Google Scholar
• McNamara D J, Davidson N O, Samuel P, Ahrens E H. Cholesterol absorption in man, Effect of administration of clofibrate and/or cholestyramine. J Lipid Res 1980; 21: 1058–64
   PubMed Web of Science ®Google Scholar
• Gylling H, Vanhanen H, Miettinen T A. Effects of acipimox and cholestyramine on serum lipoproteins, non-cholesterol sterols and cholesterol absorption and elimination. Eur J Clin Pharmacol 1989; 37: 111–5
   PubMedGoogle Scholar
• Weintraub M S, Eisenberg S, Breslow J L. Lovastatin reduces postprandial lipoprotein levels in hypercholesterolemic patients with mild hypertriglyceridemia. Eur J Clin Invest 1989; 19: 480–5
   PubMedGoogle Scholar
• Eley K G, Bennet A, Stockley H L. The effects of prostaglandins E1 E2 F1a and F2a on guinea-pig ileal and colonic peristalsis. J Pharm Pharmacol 1977; 29: 276–80
   PubMedGoogle Scholar
• Cummings J H, Newman A, Misiewicz J J, Milton-Thompson G J, Billings J A. Effect of intravenous prostaglandin F2a on small intestinal function in man. Nature 1973; 243: 169–71
   PubMedGoogle Scholar
• Percy W H, Burton M B, Fallick F, Burakoff R. A comparison in vitro of human and rabbit distal colonic muscle responses to inflammatory mediators. Gastroenterology 1990; 5: 1324–32
   Google Scholar
• Ponz de Leon M, Iori R, Barbolini G, Pompei G, Zaniol P, Carulli N. Influence of small-bowel transit time on dietary cholesterol absorption in human beings. N Engl J Med 1982; 307: 102–3
   PubMed Web of Science ®Google Scholar
• Koivisto P, Miettinen T A. Adaptation of cholesterol and bile acid metabolism and vitamin B12 absorption in the long-term follow-up after partial ileal bypass. Gastroenterology 1986; 90: 984–90
   PubMed Web of Science ®Google Scholar